Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: the patient is a 45-year-old female discharged on after a long hospitalization course for thrombotic thrombocytopenic purpura, hemolytic- uremic syndrome, septic shock, ____________, pulmonary embolus, deep venous thrombosis, gastrointestinal bleed from colonic ulcer, off anticoagulation from to , with an inferior vena cava filter temporarily placed on . the patient was discharged to an acute rehabilitation and was to start lovenox b.i.d. 110 subcu on . this was to be continued until the filter was removed and the patient transitioned to coumadin. however, at the rehab she did not receive any lovenox and thought she was on coumadin although it is unclear from her records if she was ever on coumadin. the patient reports increasing lower extremity edema, left much greater than right, over the last week. the rehab m.d. attributed this to patient being out of bed and from physical therapy. the patient reports that she walked the entire length of the parking lot yesterday. the edema increased, however, with mild discomfort noting dyspnea and shortness of breath. no chest pain. the patient saw dr. as an outpatient today and, as he was concerned, he sent her to the emergency department. her __________ were negative for multiple clots bilaterally. past medical history: bipolar disease. thrombotic thrombocytopenic purpura in . hemolytic-uremic syndrome in . pulmonary embolus and deep venous thrombosis per pe on . hypertension. diabetes likely secondary to steroids. recent gastrointestinal bleed with colonic ulcer. septic shock with disseminated intravascular coagulopathy. acute renal failure. ___________ with plasmapheresis. hepatic abscesses. right hand calcifications. edema secondary to infusion of calcium. allergies: demerol. physical examination on admission: temperature 98.0, blood pressure 130/94, heart rate 108, respiratory rate 16, 98 percent on room air. general: the patient was obese in no apparent distress, pleasant and in bed. heent: moist mucus membranes. extraocular motions intact. no icterus. no lymphadenopathy. cardiovascular: regular rate. no murmurs, rubs or gallops. normal s1, s2. pulmonary: clear to auscultation with poor inspiration. abdomen: obese, soft, non-tender, non-distended. extremities: right hand with healing calcium ulcerations. large edematous non-pitting lower extremity edema, left greater than right. pulses intact. neurological: awake, alert and oriented times three. strength 5/5 bilaterally. cranial nerves ii through xii intact. discharge medications: on : 1. seroquel 75 q. hs. 2. topiramate 50 b.i.d. 3. mirtazepine 15 q. hs. 4. folic acid one q. day. 5. calcium carbonate 1000 t.i.d. 6. miconazole powder. 7. ativan 0.5 q. 6h. p.r.n. 8. ferrous sulfate 325 q. day. 9. bismuth p.r.n. 10. epo-alpha 10,000 units three times a week. 11. simethicone p.r.n. 12. oxycodone 10 q. 4-6h. p.r.n. 13. benadryl. 14. maalox. 15. docusate two b.i.d. 16. atenolol 75 q. day. 17. lisinopril 40 q. day. 18. protonix 40 q. day. 19. glargine 15 q. hs. 20. prednisone 20 q. day. 21. lovenox which patient did not receive. social history: no tobacco, no alcohol, no intravenous drug abuse. comes from acute rehabilitation. family history: no acute diseases. radiology: bilateral lower extremity ultrasound showed occlusive thrombus in the left common femoral vein, greater femoral vein, superior femoral vein and right common femoral vein and popliteal. hospital course: 1. deep venous thrombosis: the patient had a large clot present on initial examination as mentioned above. the patient subsequently had a venogram on which showed persistent clot. in the setting of inferior vena cava filter with extensive lower extremity dvt, hematology/oncology was consulted in addition to interventional radiology being consulted. ir, hematology/oncology and the primary team recommended proceeding with tpa to break these clots. tpa was initiated with transfers to the intensive care unit. tpa was given 1 mg per hour times two hours and then decreased to 0.5 mg per hour. the patient was also initiated on a heparin drip at this time. the patient, after given tpa, returned to ir on for a repeat venogram which showed good results with only a small amount of residual thrombus in the left femoral vein and common femoral vein. the common femoral vein, iliac vein and inferior vena cava were all patent. the patient was subsequently started on a heparin drip and coumadin until the inr was therapeutic with inr between 2 and 3 as goal. the patient was overlapped with heparin and coumadin for 24 hours. additionally, the patient was maintained on a heparin drip for at least five days in order for inr to become therapeutic. on day before discharge interventional radiology attempted to remove her er ivc filter, however it had spontaneously become lodged in a position that did not allow retrieval despite multiple attempt. vascular surgery also reviewed the angiogram and agreed that this would be extremely difficult if at all possible to retrieve. ivir offered the patient to try a second approach that they felt had < 50% chance of success, however she refused. the patient is to continue on coumadin with goal inr 2 to 3 for indefinitely given her ivc filter and there prothrombic state. hematology/oncology. 1. pulmonary embolus/inferior vena cava filter: no clinical evidence of pe during this admission. again, patient had her ivc filter removed during this admission with anticoagulation as above. 1. anemia: patient has a history of colonic ulcers and gastrointestinal bleeds. the patient was not transfused while on the floor and maintained a stable hematocrit during this admission. 1. history of thrombotic thrombocytopenic purpura/hemolytic- uremic syndrome: patient's platelet count remained stable during this admission. hematology/oncology was consulted during this admission and followed the patient throughout this whole hospitalization course. patient was continued on a steroid taper per hematology/oncology recommendations. the patient's prednisone was continued at 10 mg p.o. q. day on discharge. per hematology/oncology, patient can slowly taper down her prednisone by 5 mg every two weeks. therefore, patient on should be changed to 5 mg p.o. q. day. 1. diabetes type 2: this is most likely steroid induced as patient's hemoglobin a1c is less than 5. the patient is to continue lentis on sliding scale for right now. at acute rehabilitation can slowly be tapered off as patient is weaned off steroids. 1. status post acute renal failure: the patient had acute renal failure likely secondary to hypovolemia. the patient's creatinine is back to baseline on discharge. 1. hypertension: patient was stable on a beta blocker and ace inhibitor which were both increased during this admission. a third , hydrochlorothiazide, was added three days before discharge to goal blood pressure less than 130/80. 1. history of bipolar disorder and anxiety: patient was continued on her seroquel and remeron. discharge diagnoses: include: deep venous thrombosis. diabetes type 2. hypertension. hemolytic-uremic syndrome/thrombotic thrombocytopenic purpura. colonic ulcer. hypertension. bipolar disorder. anxiety disorder. follow-up plan: the patient is to follow up with dr. on at 2:40 p.m. the patient is to follow up with primary care physician, . , in one to two weeks and should call to schedule an appointment. discharge medications: include: 1. seroquel 35 mg p.o. q. hs. 2. mirtazapine 50 mg p.o. q. hs. 3. folic acid 1 mg p.o. q. day. 4. calcium carbonate 1000 mg p.o. q.i.d. 5. miconazole powder one application b.i.d. 6. lorazepam 0.5 mg p.o. q. 6h. p.r.n. 7. bismuth subsalicylate 262 mg tablets two tablets p.o. t.i.d. 8. epo-alpha 10,000 units three times a week. 9. simethicone 80 mg p.o. t.i.d. p.r.n. 10. oxycodone 5 mg p.o. q. 4-6h. p.r.n. 11. maalox 15-30 cc p.o. q.i.d. p.r.n. 12. lisinopril 40 mg p.o. q. day. 13. pantoprazole 40 mg p.o. q. day. 14. senna one tablet p.o. b.i.d. 15. prednisone 10 mg p.o. q. day until where patient is to be changed to 5 mg p.o. q. day which should end on . 16. docusate sodium 100 mg p.o. b.i.d. 17. bisacodyl two tablets b.i.d. p.r.n. 18. atenolol 100 mg p.o. q. day. 19. coumadin 5 mg p.o. q. hs.; however, inr should be checked q.o.d. for the next one week to stabilize inr between 2 and 3. after that m.d. can choose how often to check inr values. 20. hydrochlorothiazide 25 mg p.o. q. day. 21. lentis. 22. glargine 15 units q. hs. dr., 12-ahu procedure: venous catheterization, not elsewhere classified injection or infusion of thrombolytic agent arteriography of femoral and other lower extremity arteries phlebography of femoral and other lower extremity veins using contrast material transfusion of other serum diagnoses: other specified disorders of pancreatic internal secretion acute kidney failure, unspecified iron deficiency anemia secondary to blood loss (chronic) long-term (current) use of anticoagulants thrombotic microangiopathy bipolar i disorder, most recent episode (or current) unspecified ulcer of heel and midfoot 

Answer: The patient is high likely exposed to